Document Detail

Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.
MedLine Citation:
PMID:  17665155     Owner:  NLM     Status:  MEDLINE    
Contrast-enhanced magnetic resonance (MR) imaging is considered the most sensitive method for detecting tumors in the central nervous system (CNS). The primary objective is to improve lesion detection, delineation, and characterization (benign or malignant) in order to more accurately define the location, extent, and type of disease and the appropriate treatment option for improved patient outcome (surgical intervention, radiation therapy or cytotoxic chemotherapy). This article reviews the various types of tumor occurring in the brain and the specific role of contrast-enhanced MR imaging for the evaluation of these tumors. Emphasis is placed on the value of contrast-enhanced MR imaging in the evaluation of primary intra-axial brain lesions and how high relaxivity contrast agents such as MultiHance (Bracco Imaging, Milan, Italy) might improve detection, treatment planning, and follow-up.
Piero Picozzi; Miles A Kirchin
Related Documents :
16955025 - Follicular lymphoma of the dura: case report.
22957635 - Toward truly combined pet/ct imaging using pet detectors and photon counting ct with it...
24458855 - A possible case of acute disseminated encephalomyelitis after japanese encephalitis.
15095965 - Molecular analysis of astrocytoma associated with turcot syndrome type 1--case report.
22088805 - Does hyperglycemia affect the diagnostic value of 18f-fdg pet/ct?
8686615 - Mr imaging evaluation of hemidiaphragms in acute blunt trauma: experience with 16 patie...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neuroradiology     Volume:  49 Suppl 1     ISSN:  0028-3940     ISO Abbreviation:  Neuroradiology     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-31     Completed Date:  2007-12-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1302751     Medline TA:  Neuroradiology     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  S27-34     Citation Subset:  IM    
Department of Neurosurgery, San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Neoplasms / pathology*,  therapy
Contrast Media*
Decision Making, Computer-Assisted
Magnetic Resonance Imaging*
Meglumine / analogs & derivatives*,  diagnostic use
Organometallic Compounds / diagnostic use*
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 113662-23-0/gadobenic acid; 6284-40-8/Meglumine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High-concentration contrast media (HCCM) in CT angiography of the carotid system: impact on therapeu...
Next Document:  Contrast-enhanced time-resolved 3-D MRA: applications in neurosurgery and interventional neuroradiol...